| Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 220.66B | 221.88B | 189.03B | 201.03B | 190.69B | 184.48B |
| Gross Profit | 40.66B | 38.93B | 23.99B | 28.53B | 25.58B | 25.41B |
| EBITDA | 29.04B | 26.86B | 429.00M | 16.57B | 14.68B | 13.15B |
| Net Income | 21.04B | 19.89B | -6.91B | 7.94B | 6.68B | 8.12B |
Balance Sheet | ||||||
| Total Assets | 287.79B | 293.90B | 272.51B | 280.54B | 279.73B | 276.52B |
| Cash, Cash Equivalents and Short-Term Investments | 44.17B | 42.34B | 37.03B | 36.34B | 35.06B | 37.77B |
| Total Debt | 4.05B | 480.00M | 382.00M | 322.00M | 544.00M | 996.00M |
| Total Liabilities | 58.56B | 64.30B | 70.45B | 66.63B | 63.40B | 57.77B |
| Stockholders Equity | 226.17B | 226.57B | 199.44B | 211.10B | 213.22B | 214.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.22B | 2.10B | 10.34B | 6.30B | 7.65B |
| Operating Cash Flow | 0.00 | 22.75B | 6.18B | 13.72B | 7.97B | 9.12B |
| Investing Cash Flow | 0.00 | -11.53B | 4.84B | -6.10B | -4.33B | 6.34B |
| Financing Cash Flow | 0.00 | -7.64B | -7.51B | -7.32B | -8.52B | -7.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥180.21B | 11.53 | ― | 3.09% | 3.75% | 87.00% | |
77 Outperform | ¥73.79B | 14.22 | ― | 4.38% | -0.84% | -1.80% | |
76 Outperform | ¥247.49B | 11.49 | 9.20% | 2.78% | 1.31% | 59.20% | |
74 Outperform | ¥42.77B | 14.47 | ― | 2.01% | 14.48% | 122.79% | |
73 Outperform | ¥152.32B | 12.36 | ― | 2.81% | 8.83% | 49.49% | |
68 Neutral | ¥193.52B | 15.91 | ― | 2.87% | 6.66% | 46.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
CHUDENKO CORPORATION has decided to sell shares held by shareholders whose whereabouts are unknown, as part of an effort to enhance the efficiency of share administration. This move is expected to streamline operations and could potentially impact shareholder dynamics, as shares unclaimed for over five years will be sold if no objections are raised by February 6, 2026.
CHUDENKO Corporation reported a decrease in net sales for the six months ended September 30, 2025, at ¥95,754 million, a 2.5% drop from the previous year. However, the company saw significant growth in operating profit, ordinary profit, and profit attributable to owners of the parent, with increases of 29.4%, 19.7%, and 21.8% respectively, indicating improved operational efficiency and profitability despite lower sales. The company also announced an increase in annual dividends per share, reflecting confidence in future earnings.